Back to Speakers
Jason Temple

Jason Temple

Attorney/ShareholderBrown & Fortunato
Tue Mar 23•2:15 PM – 3:15 PM

Private Equity and DME: Understanding New Challenges and Opportunities

Private equity (PE) has become one of the most influential forces shaping the durable medical equipment (DME) industry. Over the past decade, investme

…

Private equity (PE) has become one of the most influential forces shaping the durable medical equipment (DME) industry. Over the past decade, investment firms have committed billions of dollars to healthcare services, fueling consolidation among DME

…

Private equity (PE) has become one of the most influential forces shaping the durable medical equipment (DME) industry. Over the past decade, investment firms have committed billions of dollars to healthcare services, fueling consolidation among DME providers and creating larger, multi-state organizations with greater operational scale and access to capital.

As these investment-backed companies expand through acquisitions, independent providers a

…

Private equity (PE) has become one of the most influential forces shaping the durable medical equipment (DME) industry. Over the past decade, investment firms have committed billions of dollars to healthcare services, fueling consolidation among DME providers and creating larger, multi-state organizations with greater operational scale and access to capital.

As these investment-backed companies expand through acquisitions, independent providers are facing new competitive realities. Many owners are receiving acquisition offers for the first time, while others are evaluating whether to grow through acquisition, seek outside investment, or remain independent.

This session examines how private equity is transforming the DME industry and what that means for provider owners and executives. Participants will learn why DME has become an attractive investment sector, how private equity firms identify acquisition targets, what characteristics drive valuation, and how platform companies execute acquisition strategies.

Rather than advocating for or against private equity, this session provides an objective, business-focused framework for understanding one of the most significant shifts affecting the DME industry today.

Show MoreClick the title to see all detailsShow More
Legislative Regulatory LegalSession Track
Jason Temple
Jason TempleAttorney/Shareholder, Brown & Fortunato
Bradley Smith
Bradley SmithManaging Director/Partner, Vertess